Manage subscriptions   |   FAQ   |   Report Bugs/Errors/Omissions to
2 entries found

Alzheimer's Drug Discovery Foundation (US)

Sorry, no opportunities were found, please adjust your filters or try another search


Core Funding Programs International Verified Date 2 2 days until deadline

Deadline: December 03, 2021

The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias. ADDF has dedicated funding to several key areas: *Translational research to develop new drugs and build preclinical evidence *IND-enabling studies and early-stage clinical trials for novel and repurposed drugs *Development and validation of plasma, CSF, neuroimaging and digital biomarkers *Epidemiological studies and comparative effectiveness research Applications are reviewed throughout the year through our core programs.


Diagnostic Accelerator International Verified Date

Deadline: TBD

The Diagnostics Accelerator challenges the research community to develop cutting-edge biomarkers and explore novel diagnostic technologies that will aid in Alzheimer’s diagnosis and clinical trial design. Research funded to date focuses on various methods and targets including blood tests in various stages of development, as well as eye scans and digital tools.